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Background: The COVID-19 pandemic has created a need to prioritize care because
of limitation of resources. Owing to the heterogeneity and high prevalence of breast
cancers, the need to prioritize care in this vulnerable population is essential. While
various medical societies have published recommendations to manage breast disease
during the COVID-19 pandemic, most are focused on the Western world and do not
necessarily address the challenges of a resource-limited setting.
Aim: In this article, we describe our institutional approach for prioritizing care for
patients presenting with breast disease.
Methods and results: The breast disease management guidelines were developed
and approved with the expertise of the Multidisciplinary Breast Program Leadership
Committee (BPLC) of the Aga Khan University, Karachi, Pakistan. These guidelines
were inspired, adapted, and modified keeping in view the needs of our resource-
limited healthcare system. These recommendations are also congruent with the ethi-
cal guidelines developed by the Center of Biomedical Ethics and Culture (CBEC) at
the Sindh Institute of Urology and Transplantation (SIUT), Karachi.
Our institutional recommendations outline a framework to triage patients based on
the urgency of care, scheduling conflicts, and tumor board recommendations, opti-
mizing healthcare workers' schedules, operating room reallocation, and protocols.
We also describe the “Virtual Blended Clinics”, a resource-friendly means of con-
ducting virtual clinics and a comprehensive plan for transitioning back into the post-
COVID routine.
Conclusion: Our institutional experience may be considered as a guide during the
COVID-19 pandemic, particularly for triaging care in a resource-limited setting;
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however, these are not meant to be universally applicable, and individual cases must
be tailored based on physicians' clinical judgment to provide the best quality care.
K E YWORD S
breast cancer, clinical outcome, surgical oncology
1 | INTRODUCTION
The COVID-19 pandemic has challenged the world with unprece-
dented health, economic, and social consequences. According to the
United Nations, it is the worst crisis that the Organization has faced in
its 75-year history.1 This pandemic has disrupted the delivery of
healthcare services globally, posing additional risks to those requiring
care unrelated to COVID-19 owing to existing comorbidities. As of
13 May 2020, there have been more than 4 million confirmed cases
of COVID-19 and more than a quarter million deaths worldwide due
to the virus.2 While the COVID-19 outbreak affects all segments of
the population, it has disproportionately affected vulnerable
populations such as the elderly, the immunocompromised, patients
with disabilities or pre-existing comorbidities, and those belonging to
the lower socioeconomic status. South Asia and Africa, which com-
prise a significant number of lower and middle income countries
(LMIC) have reported at least 100 000 and 50 000 confirmed cases,
respectively.2 While these developing countries share a smaller pro-
portion of the confirmed global disease burden, this does not neces-
sarily translate into milder outcomes for these regions. The
developing world remains particularly at high risk for adverse out-
comes due to poor pre-pandemic healthcare infrastructure, limited
resources, and economic costs of lockdowns. These challenges will be
accentuated as the number of infected patients requiring critical care
rises with severe limitation of resources in these countries.
Immunocompromised patients and those with cancer have been
shown to have a higher incidence of complications and mortality from
SARS COV.3 Breast cancer is one of the most prevalent cancers in both
the developed and developing world. As hospital resources and staff
become limited during the COVID-19 pandemic, it becomes critically
important to triage patients timely and appropriately. With regard to
patients with breast diseases, it is imperative to differentiate between
patients who require urgent care and patients whose care can be
deferred without leading to worse outcomes. This is important to mitigate
the risk to these patients and to preserve precious hospital resources.
Pakistan reported its first case of COVID-19 on 26 February
2020, which was treated at our institution.4 Since then, Pakistan has
reported a minimum of 35 788 confirmed cases with at least
770 confirmed deaths.5 The case fatality rate in Pakistan is 2.1% and
the recovery rate is 28%.6 Pakistan is among the LMICs that do not
have a strong healthcare infrastructure. In light of the pandemic, our
institution aimed to implement strategies to effectively conserve
resources and limit exposure of its healthcare staff while continuing
to provide essential healthcare services to the patients. In this arti-
cle, we aim to describe and share our “institutional guidelines”
adopted to triage patients who require care for breast-related issues,
in our setting as an LMIC. There is often a gap between consensus
recommendations by professional societies and their translation into prac-
tice, particularly in developing countries. Work like ours can help provide
a template for utilization in other resource-limited countries/hospitals/
regions with modifications, as appropriate.7-9 These guidelines are meant
to aid treatment decisions in these unprecedented circumstances of the
COVID-19 pandemic and emphasize multidisciplinary care and teamwork.
They are not intended to supersede physician judgment or tumor board
decisions and are subject to modification keeping in view available
resources and COVID-19 prevalence.
2 | METHODS (DEVELOPMENT OF
RECOMMENDATIONS)
The breast disease management guidelines were developed and approved
by the multidisciplinary Breast Program Leadership Committee (BPLC) of
the Aga Khan University, Karachi, Pakistan. These guidelines were
inspired by COVID resources from the Society of Surgical Oncology
(SSO) and American Society of Breast Surgeons (ASBrS) and subsequently
adapted and modified keeping in view the needs of our resource-limited
healthcare systems. They may be utilized for other resource-limited coun-
tries/hospitals/regions with modifications, as appropriate.7-9 These rec-
ommendations are also congruent with the ethical guidelines developed
by the Center of Biomedical Ethics and Culture (CBEC) at Sindh Institute
of Urology and Transplantation (SIUT), Karachi.10
3 | RESULTS
3.1 | Triaging patients based on breast pathology
Patients are triaged based on existing pathology, tumor type, available
treatment options, and the urgency of the need for surgical treatment.
Surgical procedures put the patients as well as healthcare providers at a
heightened risk of exposure to SARS COV and have the potential to
deplete medical supplies and occupy beds that are needed for the
COVID-19 patients. Therefore, a patient's pathology is the primary
focus, with the intent of deferring surgery where safely possible, with-
out adversely impacting the quality of care and prognosis.11
• Priority A includes all those patients who have conditions that are
immediately life-threatening or symptomatic requiring urgent
treatment (see Figure 1).
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• Priority B includes all those patients who have conditions that do
not require immediate treatment but should start treatment before
the pandemic is under control. Intervention in priority B may be
altered or delayed for 4–8 weeks (see Figure 2).
• Priority C includes all those patients who have conditions that can
be safely deferred until after the pandemic is under control. These
groupings were defined for each specialty such as surgery, medical
oncology, radiation oncology, breast imaging, genetics, and pathol-
ogy to facilitate decision making in the respective disciplines (see
Figure 3).
3.2 | Tumor board
A multidisciplinary tumor board meets through video conference once
a week where only cases warranting decision making are discussed.
For an informed decision, history, physical exam findings, other
F IGURE 1 Priority A: Urgent Care
F IGURE 2 Priority B: Intervention may be altered or delayed for
4–8 weeks
SATTAR ET AL. 3 of 7
comorbidities, relevant images, and pathology are reviewed, and treat-
ment decisions are made by placing each patient in one of the priority
groups A, B, or C. Where definitive care is deferred, 4–6 weeks
follow-ups are planned to monitor the patients. Based on these
follow-ups and changes in a patient's status, the categorization may
change.
3.3 | Healthcare workers' schedule
To minimize exposure to healthcare professionals (HCPs), the daily
schedule is planned on a rotational basis for all providers including
F IGURE 3 Priority C: Intervention may be delayed until the
pandemic is under control*. *Assuming the pandemic will be under
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nurses and technicians, allowing each person at least 1 to 2 days off
in a week and, where possible, up to seven consecutive days. In cer-
tain specialties, in-patient team schedules have been formulated to
accommodate a week on and a week off schedule for healthcare pro-
viders to minimize exposure. A third team is kept as a backup to
replace any staff that warrants isolation/quarantine.
3.4 | Operating rooms reallocation
Operating rooms (OR) were reallocated to preserve personal protective
equipment supplies and limit the exposure to OR personnel by maintaining
a rotational schedule. From our usual process of assigning ORs to a partic-
ular surgeon, we switched to assigning operating rooms based on spe-
cialty. An OR suite consisting of three ORs, a pre-op area, and a recovery
room that were independent of the other 14 ORs were converted into
negative pressure rooms and reserved for COVID-suspected or COVID-
positive patients only. All semi-elective surgical cases undergo a COVID
test 48 hours before surgery. For cost containment, the test is performed
as a pooled test of eight patients using PCR. If the pool tests positive, each
sample is re-run individually. With the expected rate of positive samples
being under 10%, this has been cost-effective (Table 1).
3.5 | Operating room protocol
Since all specialties use the OR)facilities, a color-coded system is in
place to prioritize cases based on urgency. Refer to the OR flowchart
(see Figure 4). The following color codes are followed in the flow
chart.
• Red emergency: Urgent/emergent/life or organ-threatening sur-
gery to be performed within 1 h. If the emergency OR is occupied,
any nonurgent case is delayed/procedure will be stopped, prefera-
bly in the same specialty where possible.
• Orange emergency or Semi-emergency: Such cases are taken up
as soon as OR becomes available or semi-elective list is completed
for the day for that particular specialty.
• Semi-Elective: All breast oncology cases are in this category.
3.6 | Approval of cases by clinical leaders
To maintain transparency and adherence to all institutional guidelines,
all surgical cases need to be approved by the Section Heads/Division




clinical decision on 
initial encounter has to be done 
same day 
elective semi-elective orange emergency red emergency 
check again for   
feasibility next week screen for COVID -19 screen for COVID -19                  
screen for COVID -19
discuss the case with 
service line chief or 
section head 
submit the case to the 
service line 3 days 
ahead 
service line submits the 
list to booking office 
6 pm, 2 days ahead 
approval by service line 
chief or section head 
discussion between consultant
surgeon and coordinator or
consultant anesthesiologist  
book the case and 
proceed when called 
discussion between consultant 
surgeon and consultant 
anesthesiologist 
book the case and proceed 
list published after final 
approval 1 day ahead 
remember, every case 
increases the risk of 
infecting our co-workers
F IGURE 4 Process flow for surgical procedures12
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Chiefs/Chairs of the Department of Surgery and Anesthesia before
being confirmed on the surgical schedule. The approvals are in line
with the institutional guidelines, Figures 1–3. From the period
18 March through 12 May 2020, a decrease in surgical volume was
seen when compared to the same period in 2019 (48 breast surgical
procedures in 2019 vs 30 breast surgical cases in 2020).
3.7 | Virtual and blended clinics
New patients with urgent issues such as lumps or known cancers are
given urgent appointments. Nonurgent issues are deferred where pos-
sible or addressed via virtual clinics. New patients are seen in “Blended
Clinics.” In a blended clinic, a patient arrives at the hospital/clinic build-
ing and is met by a screening team in the open, where a brief, COVID-
focused history and temperature are taken. If the patient is considered
high-risk, he or she is referred to the designated COVID testing area. If
cleared for a physical clinical encounter, the patient is allowed to pro-
ceed into the clinical area and get registered. In-person visits are spaced
out on the schedule to prevent crowding of the clinical areas. Seating in
the waiting area has been rearranged to maintain physical distance. All
patients are also mandated to wear a mask and may be accompanied
by only one attendant. In a blended clinic, the patient encounter is initi-
ated with a phone call from the physician to the patient in the waiting
room. A detailed history is taken and images are reviewed. The patient
is then invited to the clinical exam area for a brief face-to-face encoun-
ter with the clinician, who uses personal protective equipment (PPE).
This is followed up with a second phone call for counseling and instruc-
tions. Using this technique, we have been able to limit exposure times
without compromising care.
Most clinic slots are utilized for follow-up patients with unre-
solved issues such as ongoing investigations for the diagnosis of
malignancy or those on active treatment. All follow-up appointments
are virtual. Since many of our patients come from less developed parts
of the country, they may not have access to a computer/internet or
may not have the technical expertise to use these services. Therefore,
our virtual clinics are based on telephonic conversations. If there is a
need for a physical exam, and the patient is in close proximity to the
hospital, they are seen the same day or during the next clinic. Patients
may elect to send their images of a wound or a lesion as necessary
over a freeware, cross-platform messaging, and voice over IP service
called WhatsApp (popular in Pakistan) to the “Breast Hotline” number.
The hotline phone is carried by our senior breast surgery nurse
24 hours a day. Prescriptions and requests/orders for imaging as well
as details of follow-ups are also sent to the patients through
WhatsApp. All routine survivor visits and routine follow-up imaging
have been deferred by 3 months.
3.8 | Prescriptions
Patients have the option of filling in their prescriptions virtually by
sending a copy of the prescription though email or WhatsApp to the
AKU Pharmacy. The dispensed medication is then delivered to the
patient's home, thus obviating the need for the patient to leave home.
3.9 | Transition plan
Now that we have been successfully following the above plan for over
a month, we are now in the process of developing a strategy to
smoothly transition back into usual routine care. The transition will be
slow and deliberate. Lists of patients that were triaged into groups B
and C are maintained. When the COVID curve starts to flatten, we
will be able to contact our patients from groups B and C and prioritize
their surgical care as needed along with those who may need urgent
care. How long the tele-clinics will continue will be partly dictated by
the COVID disease burden and hesitancy of patients to attend in per-
son. The silver lining may be the opportunity to experiment with this
model and determine its success, especially in patients who come
from far-flung areas to our academic medical center to seek special-
ized care. In the long term, allocating a certain number of clinic slots
for teleconsultation may be an opportunity to offer expert advice to
patients in remote areas or even patients outside the country.
4 | DISCUSSION
COVID-19 pandemic has disrupted the global healthcare infrastructure.
While cancer management is already challenging in resource-limited
settings, recommendations from the international guidelines are appli-
cable to low resource settings in many cases. For example, wearing
cloth masks in public and saving surgical masks to be used within the
health facilities is considered convenient to LMIC. Also, educational
materials and programs directed to cancer patients and promoting
proper hygiene and infection prevention measures are feasible.13
However, these recommendations may be limited by complex
geographic situations, unavailability of equipment or means of com-
munication (telemedicine), limited expertise of the staff, and local
needs of individual countries.14 The uncertainty of the pandemic's
duration, the strain on resources during the pandemic, and the
impact of BC treatment delay on survival, along with the known BC
situation in LMIC, mandate the implementation of resource-
stratified guidelines as previously suggested by Breast Global Health
Initiative.15
Consequently, several guidelines have been published to manage
cancer care in resource-limited settings and with a consensus to triage
and prioritize cancer surgery aimed to preserve the patient's function,
long-term prognosis, and quality of life. The focus of current cancer sur-
gery care has shifted into the establishment of definitive diagnosis, stag-
ing, and selected essential surgery. These guidelines explore the
possibility of application in LMICs and hypothesize their practicality. In
contrast, we describe our experience, which has been in place since the
beginning of the COVID-19 pandemic. With adaptions and alterations to
suit the need of the hour, our guidelines provide a framework for coun-
tries that may be struggling to manage a high influx of COVID-19 cases.
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Furthermore, published literature for breast disease management in
LMICs details the criteria of triaging patients for screening, imaging,
work-up, surgical, medical, and radiation oncology, follow-up care, post-
operative management, supportive care, and palliation. Apart from detail-
ing the implemented and workable guidelines of the above-mentioned
categories, our recommendations also describe prioritization in genetics,
pathology, staff management, tumor board conductance, operating room
protocols, resource allocation, as well as a transition-back plan. The
above-mentioned categories together form a holistic multidisciplinary
approach and can also be implemented in settings where an infrastruc-
ture was previously not in place and requires a new pandemic set-up.
For settings that lack a high-quality telecommunication network to
conduct long-distance telecommunication, we provide a cost-effective
concept of “blended” clinics. Blended clinics can minimize the patient/
physician contact without compromising the quality of care, whose
implementation requires a basic infrastructure consisting of a low-
quality internet/landline network and availability of PPE.
In a nutshell, almost all recommendations describe means of
delaying less urgent treatment and prioritizing breast cancer care
carefully based on individual patients' needs as dictated by the dis-
ease, ground reality, and resources.13,14,16
5 | CONCLUSION
In the wake of the COVID-19 pandemic, as hospital resources and staff
become limited, while it is important to prioritize care, it is equally impor-
tant for the HCPs and the institutional leadership to communicate clearly
and regularly. No plan can be etched in stone and all stakeholders have
to be ready and willing to respond quickly to the changing needs based
on rapidly changing circumstances. Owing to a lack of existing evidence,
our experience may be considered as a guide during the COVID-19 pan-
demic, particularly for triaging care in a resource-limited setting.
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